• EdU Flow Cytometry Assay Kits (Cy5): Advanced Proliferation

  2026-08-03

  Explore EdU Flow Cytometry Assay Kits (Cy5) for precise cell cycle S-phase DNA synthesis measurement. This article reveals new immunometabolic applications in cancer research, building on recent breakthroughs in tumor immune evasion.

• Butylated Hydroxyanisole (BHA): Applied Protocols for Oxidat

  2026-08-03

  Butylated hydroxyanisole (BHA) stands out as a high-purity, reproducible antioxidant for dissecting oxidative stress–driven pathways in cellular and peptide research. This article delivers an actionable workflow, troubleshooting strategies, and evidence-based protocol refinements, with insights drawn from recent advances in GnRH antagonist design and ROS modulation.

• iPSC-Based Models Advance Cystic Fibrosis Drug Testing

  2026-08-02

  The reference study pioneers the use of induced pluripotent stem cell (iPSC)-derived airway epithelial cells to model cystic fibrosis (CF) and test CFTR modulators across diverse genetic backgrounds. This platform addresses the challenge of rare CFTR variants and improves preclinical assessment, with clear implications for personalized and translational research.

• LY294002: Applied PI3K/Akt/mTOR Inhibition in Translational

  2026-08-01

  LY294002 is the go-to reversible PI3K/Akt/mTOR pathway inhibitor for dissecting cell signaling, apoptosis, and autophagy in cancer and inflammation models. This guide translates recent mechanistic breakthroughs and workflow best practices into actionable protocols, troubleshooting, and cutting-edge research applications, drawing on APExBIO’s trusted quality.

• Nirmatrelvir (PF-07321332): Deep Mechanistic Insights for SA

  2026-07-31

  Discover how Nirmatrelvir (PF-07321332) disrupts SARS-CoV-2 replication at the molecular level and why its selectivity for 3CL protease sets a new benchmark in antiviral therapeutics research. Gain practical guidance and scientific context for advanced COVID-19 studies.

• SAR405: Selective Vps34 Inhibitor for Autophagy Research

  2026-07-31

  SAR405 is a highly selective Vps34 inhibitor that blocks autophagy initiation by targeting class III PI3K. Its nanomolar potency and specificity enable precise dissection of vesicle trafficking and lysosome function in cellular models.

• Sodium Orthovanadate: Precision in Phosphorylation State Pre

  2026-07-30

  Sodium Orthovanadate (Na3VO4) is a gold standard for preserving phosphorylation in kinase and metabolic assays, ensuring reliable readouts in complex signal transduction studies. This article delivers actionable workflows, troubleshooting strategies, and translates recent insights from insulin resistance research into practical enhancements for bench scientists.

• Cardiogreen (Indocyanine Green): Beyond Diagnostics to Preci

  2026-07-30

  Explore how Cardiogreen (Indocyanine green) is revolutionizing both diagnostic imaging and advanced photodynamic therapy. Uncover unique mechanistic insights, protocol guidance, and translational opportunities that set this vascular dye apart in biomedical research.

• Redefining Protein Preservation: EDTA-Free Inhibitors in Tra

  2026-07-29

  This thought-leadership article explores the mechanistic and strategic rationale for adopting EDTA-free protease inhibitor cocktails—specifically the Protease Inhibitor Cocktail (EDTA-Free, 100X in DMSO) from APExBIO—in advanced translational neuroscience workflows. Integrating recent findings on Eftud2 deficiency-triggered ferroptosis in Purkinje cells, we demonstrate how precise protease inhibition can preserve labile post-translational modifications and cellular phenotypes essential for unraveling disease mechanisms and therapeutic strategies.

• Pepstatin A: Next-Gen Aspartic Protease Inhibition in Cell B

  2026-07-29

  Explore Pepstatin A as a high-precision aspartic protease inhibitor for advanced cellular modeling. This article delves into mechanistic depth and reveals new insights for optimizing viral protein processing and osteoclast differentiation inhibition.

• (S)-(+)-Methoprene: Mechanisms and Benchmarks in JH Analog R

  2026-07-28

  (S)-(+)-Methoprene is a potent juvenile hormone analog that selectively activates the Methoprene-tolerant receptor, blocking insect metamorphosis with high specificity. Its low mammalian toxicity and robust performance in hormone-regulated developmental studies make it a gold-standard research tool.

• Leucomycin (Kitasamycin): Mechanistic Precision and Resistan

  2026-07-28

  Explore the advanced molecular action and resistance dynamics of Leucomycin (kitasamycin) in antibacterial research. This article uniquely bridges mechanistic depth with practical assay implications for translational inhibition and macrolide resistance studies.

• M344 Outperforms Vorinostat in Neuroblastoma HDAC Inhibition

  2026-07-27

  Brumfield et al. demonstrate that the HDAC inhibitor M344 robustly induces histone acetylation, cell cycle arrest, and apoptosis in neuroblastoma, suppressing tumor growth more effectively than Vorinostat across cell-based and in vivo models. Their findings clarify HDAC inhibitor mechanisms and highlight new directions for pediatric oncology research.

• BIBR 1532 Telomerase Inhibitor: Applied Workflows & Troubles

  2026-07-27

  BIBR 1532 empowers researchers to dissect telomerase-driven oncogenic processes with high selectivity and robust assay performance. This article translates bench experience and recent literature into actionable workflows, optimization strategies, and troubleshooting for advanced telomerase inhibition studies.

• OXER1 Signaling Safeguards Intestinal Barriers from Oxidativ

  2026-07-26

  This study uncovers a conserved, non-immune function for the GPCR OXER1 in maintaining intestinal epithelial barrier integrity under oxidative stress. By leveraging zebrafish models and mechanistic assays, the authors demonstrate that OXER1-driven signaling through 5-KETE orchestrates redox adaptation, with implications for inflammation and tissue resilience in mucosal environments.

16650 records 1/1110 page Next 12345 下5页 Last page